Prognosis and Treatment of Hepatocellular Carcinoma

Dear Colleagues,

As you know, prognostic prediction and treatment allocation are extremely complex processes in patients with hepatocellular carcinoma, because this neoplasm arises, in most cases, in patients with cirrhosis and additional comorbidities.

This Special Issue on “Prognosis and Treatment of Hepatocellular Carcinoma” will address the current efforts and advances in prognostic modeling and treatment of hepatocellular carcinoma.

In particular, the first aim of this Special Issue will be to describe the different prognostic systems and treatment algorithms that have been proposed for the general population with hepatocellular carcinoma.

As the second aim, special attention will be given to the evolution of the prognostic models developed for each different therapeutic approach. The Special Issue will show different perspectives of improving the activity of hepatocellular cancer treatment through the development of new systemic therapies and the development of combination radiological–surgical strategies and mini-invasive approaches with curative intent.

We hope that this Special Issue facilitates recognition and understanding of the importance of the multidisciplinary therapeutic approach and the role of prognostic factors in different therapies used for the cure of hepatocellular cancer.

Prof. Dr. Alessandro Vitale
Prof. Dr. Quirino Lai
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.